ES2811251T5 - Producción de vectores de expresión y selección de células de alta capacidad de procesamiento - Google Patents

Producción de vectores de expresión y selección de células de alta capacidad de procesamiento

Info

Publication number
ES2811251T5
ES2811251T5 ES14772197T ES14772197T ES2811251T5 ES 2811251 T5 ES2811251 T5 ES 2811251T5 ES 14772197 T ES14772197 T ES 14772197T ES 14772197 T ES14772197 T ES 14772197T ES 2811251 T5 ES2811251 T5 ES 2811251T5
Authority
ES
Spain
Prior art keywords
cells
selection
production
expression vectors
processing capacity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14772197T
Other languages
English (en)
Other versions
ES2811251T3 (es
Inventor
Allan Bradley
E-Chiang Lee
Qi Liang
Hui Liu
Andrew Wood
Vivian Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49553085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2811251(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kymab Ltd filed Critical Kymab Ltd
Application granted granted Critical
Publication of ES2811251T3 publication Critical patent/ES2811251T3/es
Publication of ES2811251T5 publication Critical patent/ES2811251T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES14772197T 2013-09-19 2014-09-18 Producción de vectores de expresión y selección de células de alta capacidad de procesamiento Active ES2811251T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201316644A GB201316644D0 (en) 2013-09-19 2013-09-19 Expression vector production & High-Throughput cell screening
PCT/GB2014/052836 WO2015040401A1 (en) 2013-09-19 2014-09-18 Expression vector production and high-throughput cell screening

Publications (2)

Publication Number Publication Date
ES2811251T3 ES2811251T3 (es) 2021-03-11
ES2811251T5 true ES2811251T5 (es) 2024-06-27

Family

ID=49553085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14772197T Active ES2811251T5 (es) 2013-09-19 2014-09-18 Producción de vectores de expresión y selección de células de alta capacidad de procesamiento

Country Status (6)

Country Link
US (3) US10337000B2 (es)
EP (2) EP3766970A1 (es)
ES (1) ES2811251T5 (es)
GB (1) GB201316644D0 (es)
TW (2) TWI667345B (es)
WO (1) WO2015040401A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201316644D0 (en) 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
EP4134378A1 (en) 2014-11-14 2023-02-15 Regeneron Pharmaceuticals, Inc. Method for generating high affinity antibodies
GB201500464D0 (en) 2015-01-12 2015-02-25 Crescendo Biolog Ltd Method of producing optimised therapeutic molecules
CN105680130A (zh) * 2016-03-31 2016-06-15 东莞洲亮通讯科技有限公司 一种一体化多系统合路平台
GB2550114A (en) 2016-05-03 2017-11-15 Kymab Ltd Methods, regimens, combinations & antagonists
KR102379464B1 (ko) 2016-06-20 2022-03-29 키맵 리미티드 항-pd-l1 항체
US9567399B1 (en) 2016-06-20 2017-02-14 Kymab Limited Antibodies and immunocytokines
WO2018029474A2 (en) 2016-08-09 2018-02-15 Kymab Limited Anti-icos antibodies
TWI760352B (zh) 2016-08-09 2022-04-11 英商克馬伯有限公司 抗ｉｃｏｓ抗體
EP3534947A1 (en) 2016-11-03 2019-09-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
GB201709808D0 (en) 2017-06-20 2017-08-02 Kymab Ltd Antibodies
GB201710984D0 (en) 2017-07-07 2017-08-23 Kymab Ltd Cells, vertebrates, populations & methods
US11629189B2 (en) 2017-12-19 2023-04-18 Kymab Limited Bispecific antibody for ICOS and PD-L1
GB201721338D0 (en) 2017-12-19 2018-01-31 Kymab Ltd Anti-icos Antibodies
GB201815629D0 (en) 2018-09-25 2018-11-07 Kymab Ltd Antagonists
GB2578867A (en) 2018-10-09 2020-06-03 Genome Res Ltd Animal models and therapeutic molecules
KR102559149B1 (ko) * 2018-10-26 2023-07-24 에프. 호프만-라 로슈 아게 재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법
WO2021037368A1 (en) * 2019-08-29 2021-03-04 Institute For Research In Biomedicine METHODS FOR RAPID cDNA PRODUCTION AND CLONING
GB2596803A (en) * 2020-07-06 2022-01-12 Petmedix Ltd Expression vector production & high-throughput cell screening
GB202012331D0 (en) 2020-08-07 2020-09-23 Petmedix Ltd Therapeutic antibodies
GB202104943D0 (en) 2021-04-07 2021-05-19 Petmedix Ltd A method for identifying lead sequences
WO2022263864A1 (en) 2021-06-17 2022-12-22 Petmedix Ltd Anti canine cd20 antibodies
WO2023152486A1 (en) 2022-02-09 2023-08-17 Petmedix Ltd Therapeutic antibodies
GB202217993D0 (en) 2022-11-30 2023-01-11 Petmedix Ltd Therapeutic antibodies

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291161B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertiore
US6258529B1 (en) 1994-12-01 2001-07-10 Oravax, Inc. PCR amplification of rearranged genomic variable regions of immunoglobulin genes
US5882856A (en) 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
US6116099A (en) 1996-11-18 2000-09-12 Carl; Richard A. Liquid dispensing apparatus having means for loading pipette tips onto fluid dispensing cylinders
US7063845B2 (en) * 2000-04-28 2006-06-20 Gemini Science, Inc. Human anti-CD40 antibodies
AU2002245272B2 (en) 2001-01-16 2006-06-29 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
JP4408628B2 (ja) * 2001-03-09 2010-02-03 ボストン プローブス，インコーポレイテッド 組み合わせオリゴマーならびにそれらの調製のためのライブラリーに適する、方法、キット、および組成物
CA2658221C (en) * 2001-04-27 2012-11-27 Kyowa Hakko Kirin Co., Ltd. Anti-cd40 monoclonal antibody
EP1369431A4 (en) * 2001-10-15 2005-01-12 Kirin Brewery ANTI-HLA-DR ANTIBODIES
US7105129B2 (en) 2002-05-15 2006-09-12 Genetix Limited Liquid handling robot for well plates
WO2003102183A1 (fr) * 2002-06-03 2003-12-11 Dnavec Research Inc. Vecteurs de paramyxovirus codant pour un anticorps et son utilisation
AU2003244159A1 (en) * 2002-07-01 2004-01-19 Hidechika Okada HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
AU2004309373A1 (en) * 2003-12-22 2005-07-14 Amgen Inc. Methods for identifying functional antibodies
CA2533219A1 (en) 2005-12-02 2007-06-02 Hudson Control Group, Inc. Systems and methods for automated proteomics research
CN102585002A (zh) 2006-06-02 2012-07-18 瑞泽恩制药公司 人il-6受体的高亲和力抗体
EP2160469B1 (en) 2007-05-17 2018-02-28 Boehringer Ingelheim RCV GmbH & Co KG Method for producing a recombinant protein on a manufacturing scale
US8124336B2 (en) 2007-09-26 2012-02-28 Population Genetics Technologies Ltd Methods and compositions for reducing the complexity of a nucleic acid sample
US20110091896A1 (en) * 2008-06-04 2011-04-21 Shizuoka Prefecture Method for analysis/identification of antibody gene at one-cell level
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
DK2683736T3 (en) * 2011-03-09 2018-04-23 Cell Signaling Technology Inc METHODS AND REAGENTS FOR CREATING MONOCLONAL ANTIBODIES
KR20140032394A (ko) 2011-03-30 2014-03-14 내셔날 유니버시티 코포레이션 유니버시티 오브 토야마 형질 세포 또는 형질아 세포의 선택 방법, 목적 항원 특이적인 항체의 제조 방법, 신규 단일 클론 항체
EP2724157B1 (en) * 2011-06-27 2017-03-08 Valneva Method for screening cells
WO2013009967A2 (en) * 2011-07-12 2013-01-17 Xbiotech, Inc. Identifying affinity-matured human antibodies
GB201122047D0 (en) † 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
WO2013188872A1 (en) 2012-06-15 2013-12-19 The Board Of Regents Of The University Of Texas System High throughput sequencing of multiple transcripts of a single cell
CA2907570A1 (en) 2013-03-15 2014-09-18 Alder Biopharmaceuticals, Inc. Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens
GB201316644D0 (en) † 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening

Also Published As

Publication number Publication date
US20160208239A1 (en) 2016-07-21
TWI707037B (zh) 2020-10-11
US10337000B2 (en) 2019-07-02
EP3047022A1 (en) 2016-07-27
WO2015040401A1 (en) 2015-03-26
EP3047022B1 (en) 2020-07-08
TW201938791A (zh) 2019-10-01
EP3047022B2 (en) 2023-12-27
US11371042B2 (en) 2022-06-28
EP3766970A1 (en) 2021-01-20
GB201316644D0 (en) 2013-11-06
US20230049767A1 (en) 2023-02-16
TW201546280A (zh) 2015-12-16
EP3047022B8 (en) 2020-08-19
US20190300876A1 (en) 2019-10-03
TWI667345B (zh) 2019-08-01
ES2811251T3 (es) 2021-03-11

Similar Documents

Publication Publication Date Title
ES2811251T5 (es) Producción de vectores de expresión y selección de células de alta capacidad de procesamiento
DK3071223T3 (da) Cell
BR112015019373A2 (pt) processamento e transformação de biomassa
DK3351620T3 (da) Metabolsk optimeret cellekultur
ES2974764T3 (es) Determinación de refracción y de astigmatismo computarizada
PL2994528T3 (pl) Organoidy zawierające wyizolowane komórki nerkowe oraz ich zastosowania
SG11201602546RA (en) Methods of host cell modification
HUP1300561A2 (en) Computer architecture and processing
DK3077080T3 (da) Carbondioxidberigelsesproces med fugtudsving
SG11201504771RA (en) Host cells and methods of use
ITMI20131813A1 (it) Cavo di bicicletta e produzione del medesimo
IL243352A0 (en) Novel selection vectors and methods for selection of eukaryotic host cells
SG11201508013YA (en) Organizing and fast searching of data
EP2956086A4 (en) ELECTROCHEMICAL MATERIAL PROCESSING, PROCESSES AND PRODUCTION
IL245272A0 (en) pif-transfected cells and methods of use
FI20135866L (fi) Mikrobiologinen keratiinin prosessointi
EP2943982A4 (en) MEMORY CELLS AND METHODS FOR FORMING MEMORY CELLS
EP2962339A4 (en) BATTERIES AND METHOD FOR PRODUCING BATTERIES
PL2982171T3 (pl) Weryfikacja w tle małych komórek
BR112016002552A2 (pt) rimel em gel
FR3001730B1 (fr) Nouveaux metallopolymeres et leur utilisation
DK3063280T3 (da) Genelektrooverførsel ind i hudceller
CO7080238A1 (es) Biocatalizadores de células enteras en la degradación de la biomasa celulósica
ES1103005Y (es) Monedero didáctico y autocontable
ITBS20130006U1 (it) Taccuino contenuto in custodia di musicassetta